S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › 0IL6 › Research report
← 0IL6 page
XStocksXray
Market X-Ray report · 19 October 2026

F5 (0IL6)

London Exchange · UK · prices in USD · close of 19 Oct 2026

Key indicators

Last closeUSD 456.22
52-week range224.25 – 488.42
Return, 1 month / 3 months+6.8% / +11.8%
Return, 1 year / 3 years+52.5% / +191.9%
TrendUptrend
RSI (14)54
Volatility (1 year)36.3%
Worst drawdown (1 year)-25.5%
Average daily value traded0.18M USD
Dividend yield–

Market X-Ray price-based

69/ 100 · High confidence · ahead of 84% of stocks on this exchange
Trend88
Momentum86
Stability (higher is calmer)53
Liquidity35
Income–

Five-year price chart navy: price · brown: 200-day average

1092073064045022021-102023-072024-082025-092026-10

About the company

F5 is a technology company based in Seattle that provides application delivery networking and security products. Its main offerings include load balancing and traffic management appliances, application security and firewall tools, and software for managing how applications are delivered across data centres and cloud environments. It serves enterprises, service providers and government organisations, helping them keep applications available, fast and protected. The company also offers related support and subscription services for its hardware and software products.

F5 trades under the code 0IL6 on the London Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

F5 (0IL6) trades on the London Exchange in UK. It last closed at USD 456.22 on 19 October 2026.

Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 591 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 52.5% and over the last three months it rose 11.8%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
F5 (0IL6)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend88 · StrongTrading above its long-term averages and near its highs.
Above 200-day average27.6%
From 52-week high-5.2%
Momentum86 · StrongRising faster than most stocks on this exchange.
3-month return11.8%
6-month return46.5%
12-month return, skipping the last month42.7%
Stability (higher is calmer)53 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)36.3%
Worst drawdown, 1 year (smaller is calmer)-25.5%
Liquidity35 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.18M USD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week−4.0%
1 month+6.8%
3 months+11.8%
6 months+46.5%
1 year+52.5%
3 years+191.9%
5 years–

Signals

50-day / 200-day average425.49 / 357.54
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)18.72

Technical summary

DailyBullish9 bullish · 4 neutral · 3 bearish
WeeklyStrongly bullish11 bullish · 1 neutral · 0 bearish
MonthlyStrongly bullish7 bullish · 0 neutral · 1 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026